KURA
Kura Oncology, Inc.
NASDAQ · Healthcare · Biotechnology · US
$11.73
+0.09%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- -$0.84
- Revenue estimate
- $23.8M
Latest reported
- Last report date
- Aug 12, 2026
- EPS actual
- -$0.77
- EPS estimate
- -$0.88
- Revenue actual
- $20.9M
- Revenue estimate
- $20.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 8
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -156.5%
- Revenue beats (12Q)
- 2
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $31
- PT range
- $24 – $38
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 12, 2026 | -$0.88 | -$0.77 | Beat 12.23% | $20.9M |
| May 12, 2026 | -$0.88 | -$0.83 | Beat 5.68% | $18.3M |
| Mar 5, 2026 | -$0.64 | -$0.92 | Miss -43.98% | $17.3M |
| Aug 7, 2025 | $0.15 | -$0.75 | Miss -600.00% | $15.3M |
| May 1, 2025 | -$0.51 | -$0.66 | Miss -29.41% | $14.1M |
| Feb 26, 2025 | -$0.65 | -$0.22 | Beat 66.15% | $53.9M |
| Nov 7, 2024 | -$0.64 | -$0.63 | Beat 1.56% | — |
| May 2, 2024 | -$0.56 | -$0.59 | Miss -5.36% | — |
| Feb 27, 2024 | -$0.56 | -$0.55 | Beat 1.79% | $1.3M |
| Nov 2, 2023 | -$0.56 | -$0.50 | Beat 10.71% | — |
| Aug 3, 2023 | -$0.57 | -$0.53 | Beat 7.02% | — |
| Feb 23, 2023 | -$0.58 | -$0.49 | Beat 15.52% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026